Hide Board Information

Show Board Information

Cipher Pharmaceuticals, Inc. CPHRF

Board Mod: Add me as mod

Asst Mods:

Last Post: 12/21/2015 6:51:13 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 7

Cipher Pharmaceuticals, Inc. (OTCMRKTS: CPHRF) Stock Message Board

1. CPHRF Company Profile

    

2. CPHRF Time & Sales

    

3. CPHRF Recent News

    

4. CPHRF Filings

    

5. CPHRF Financials

    

6. CPHRF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

9	CPHR Stock is number 124 for the largest	danrocks	12/21/2015 6:51:13 PM
8	CPHR Stock is number 157 for the largest	danrocks	12/18/2015 10:59:56 PM
7	CPHR Stock is number 55 for the largest	danrocks	12/17/2015 7:06:42 PM
6	CPHR 4.45 Cipher Pharmaceuticals Inc $CPHR stock	clayton	12/16/2015 6:24:03 PM
5	CPHR Stock is number 67 for the largest	danrocks	12/16/2015 3:19:52 PM
4	CPHR Stock is number 39 for the largest	danrocks	04/17/2015 9:33:57 PM
3	Latest Cipher Pharmaceutica (CPHMF) Headlines	Stock_Tracker	03/09/2014 11:16:09 AM
2	CPHMF 7.2294 Stock Charts $CPHMF 1 Month Chart	chartguy89	03/06/2014 2:31:33 PM
1	CPHMF Stock Charts Last: +0.1247 Monday, February	chartguy89	02/24/2014 10:44:59 PM

Recent Articles

• Important Legal Insights for Easterly ROCMuni Fund Investors
• Celebrating 130 Years of Kinley's Family Heritage and Success
• Exploring the KAT6 Inhibitors Market Potential for the Future
• Snap Inc. Class Action Lawsuit Update for Investors
• Lantheus Holdings, Inc. Faces Class Action Lawsuit: Important Updates
• Deadline Approaches for Shareholders in Lineage, Inc. Lawsuit
• Novo Nordisk A/S Faces Class Action with Potential Investor Impact
• Transforming Advanced Flower Capital for Future Opportunities
• Dow Inc. Faces Legal Battle Over Alleged Securities Violations
• Innovative DOT-247: Revolutionizing SiC Module Design
• Join the Class Action for Shareholders of Lockheed Martin Corp
• Discovering the Growth of Your Investment in Stifel Financial
• Regenx Tech Shares Update on Management Cease Trade Order
• Unicycive Therapeutics Faces Class Action Amid Securities Questions
• Upcoming Class Action Lawsuit Against Fiserv, Inc. Explained
• Replimune Group Faces Class Action Lawsuit - Key Details
• Tesla Faces Legal Challenges: Investors Encouraged to Act Quickly
• Sable Offshore Corp. Lawsuit: Key Insights and Deadlines Ahead
• Investors Alert: Class Action Lawsuit for Altimmune, Inc. (ALT)
• Join the Class Action Opportunity Against Neogen Corporation
• U.S. Lumber Coalition Applauds Canada's Trade Decision
• Optimizing Government Spending for Business Growth and Stability
• Hillary F. Blackburn Joins ACIP as First Pharmacist Member
• Aquatech's Bold Move with Koch's Lithium Extraction Technology
• LifeMD Investors: Class Action Lawsuit Notification Alert
• Investors of Fluor Corporation Seek Justice in Securities Case
• Explore the Exciting New Developments in Mammoth Lakes
• Exploring Advanced Flower Capital's Strategic Shift to BDC Model
• LGI Homes Launches Exciting National Sales Event for Buyers
• Reflex Advanced Materials Navigates Changes with Ruby Graphite
• Gauzy Ltd. Announces Board of Directors Update and Changes
• Kane Biotech Advances Antimicrobial Product with FDA Submission
• Theratechnologies Secures Court Approval for Future Pak Deal
• Lockheed Martin Investors Urged to Act on Legal Options
• Concentrix Celebrates Recognition as Leader in CXM Services
• Novo Nordisk A/S Class Action: Investors Can Claim Their Losses
• Replimune Group, Inc.: Key Updates and Investor Actions
• Sable Offshore Corp. Investors: Seeking Legal Guidance
• Spectrum Brands Faces Law Firm Probe Over Investor Concerns
• Analyzing Bruker Inc's Performance: Earnings and Valuation Insights
• Sphere Entertainment's $65 Million Revenue Surge: What's Next?
• Discover the Profound Growth of Canadian Pacific Kansas Stock
• Banorte Shines as the Leading Digital Banking Innovator in Latin America
• Minesto AB to Host Special Shareholder Meeting with Key Proposals
• Celebrating Innovation in Sustainable Automotive Design
• Revolutionizing Federal Contracts: Select GCR's Innovative Approach
• S&P Global Announces Q4 2025 Dividend with Shareholder Benefits
• Carlyle Secures $800 Million in Senior Notes for Expansion
• Important Deadline Approaching for Spectrum Pharmaceuticals Investors
• Understanding Recent Developments with Fiserv, Inc. (FI)